This approach reveals a DNA decision tree system for parallel computation and disease subtype classification using biomarker profiles.
DNA computing has emerged as a transformative paradigm for tackling computational problems at the molecular level, yet existing approaches remain constrained in algorithmic interpretability, efficiency, and scalability. Here we present a DNA-based decision tree system that modularly embeds classification rules into DNA strand displacement reaction cascades for interpretable decision-making across various configurations. It supports cascaded networks exceeding 10 layers, parallel computation of 13 decision trees in a Random Forest involving 333 strands, and multimode operation (linear/nonlinear, binary/multi-class, single/tandem trees), while maintaining low leakage, rapid signal propagation, and minimal computational elements. Coupled with a DNA-methylation sensing module, it translates biomarker profiles into molecular instructions for tree traversal, reproduces in-silico predictions and enables accurate disease subtype classification. The decision tree system represents an interpretable, scalable, and memory-efficient DNA computing approach and will open new avenues for programming intelligent molecular machines with broad applicability.
No takes yet. Share an insight, caveat, or question.
Junlan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: